Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Aug 27;19(10):2562–2569. doi: 10.1158/1055-9965.EPI-10-0447

Table 1.

Use of oral contraceptive (OC) at recruitment among all women and menopausal hormone therapy (HRT) among peri- and post-menopausal women in the EPIC cohort by country

Characteristic All
(n=276,451)
Denmark
(n=29,320)
Germany
(n=28,481)
Italy
(n=31,519)
Netherlands
(n=27,168)
Norway
(n=35,941)
Spain
(n=25,356)
UK
(n=56,357)
Greece
(n=15,396)
Sweden
(n=26,913)
Meningioma cases 194 28 15 18 16 43 16 23 4 31
Glioma cases 193 41 12 18 24 12 15 43 4 24
Among all women
OC ever use %
 Yes 55.9 57.6 80.8 40.4 72.7 64.1 42.1 64.9 9.6 38.8
 No 40.6 41.3 19.0 58.1 26.7 35.9 57.8 31.9 89.8 36.6
 Unknown 3.5 1.1 0.2 1.5 0.6 0 0.1 3.2 0.6 24.7
Nulliparous (%) 12.8 8.8 11.2 10.2 19.8 8.5 9.6 27.6 6.8 7.4
Mean age at first
pregnancy (SD)*
24.8 (4.4) 23.7 (4.2) 24.3 (4.4) 25.8 (4.3) 25.4 (4.2) 24.1 (4.5) 24.6 (3.9) 25.9 (4.7) 24.2 (4.7) 24.7 (4.5)
Mean age at menarche
(SD)
13.1 (1.6) 13.6 (1.6) 13.2 (1.5) 12.5 (1.5) 13.3 (1.6) 13.3 (1.4) 12.9 (1.6) 12.9 (1.6) 13.2 (1.7) 13.5 (1.5)
Hysterectomy (%) 10.2 14.8 15.0 8.9 17.4 4.7 8.4 12.5 8.2 --
Among all post or peri-
menopausal women
(n=174,134) (n=27,209) (n=15,267) (n=19,135) (n=18,157) (n=23,311) (n=11,772) (n=28,977) (n=9,736) (n=20,570)
Mean age at
menopause (SD)
48.7 (4.8) 49.0 (4.9) 49.5 (3.3) 49.0 (4.3) 48.5 (5.1) 47.7 (4.0) 48.0 (4.7) 48.3 (5.5) 47.9 (5.2) 49.2 (4.6)
HT ever use, %
 Yes 34.2 46.7 55.4 23.9 26.1 45.3 18.7 38.3 6.8 22.5
 No 58.3 51.4 36.3 74.3 72.6 54.7 80.1 56.9 92.7 33.9
 Unknown 7.4 1.9 8.3 1.8 1.3 0 1.2 4.9 0.5 43.6
Among ever HT users (n=62,092) (n=12,709) (n=8,455) (n=4,583) (n=4,739) (n=10,562) (n=2,195) (n=11,087 (n=662) (n=4,637)
Status of use
 Current 66.6 65.5 77.9 44.8 51.5 79.8 55.2 67.8 32.5 63.2
 Past 29.1 34.4 22.1 54.4 44.6 8.0 43.8 30.6 67.4 18.5
 Unknown 4.3 0.03 0 0.8 3.9 12.2 1.0 1.6 0.1 18.3
*

Among parous women

Among natural postmenopausal women